PRELIMINARY PROGRAMME
Wednesday 17th May – Day One
8:00 am – 9:00 am Registration 9:00 am – 9:30 am Opening and Welcome 9:30 am – 10:15 am Keynote Presentation: Kerstin Stenius: Towards control by management? On alcohol and drug problems in the history of Nordic welfare Chair: TBA 10:15 am – 10:45 am MORNING TEA Session Theme Development and Drug Policy Comparative analyses of drug policy Debating Drugs in Media Debating Drug Policy Reforms and drug use. Discussant chair Alejandro Madrazo Lajous TBA TBA TBA Panel 10: New Perspectives on the Aysel Sultan Lena Eriksson Santiago Cunial intersection between development and drug policy Drug policies of Azerbaijan and The needle exchange debate in Conflicts around Issues with low Germany reflected in narratives of Stockholm City Council and Swedish political salience: explaining the role of Panelists: high-risk drug user adolescents Parliament during the 21st century the Catholic Church in the debate on John Collins drug depenalization in Argentina Aileen O’Gorman (2009-2014) David Mansfield Alexander Soderholm M. Rychert, C. Wilkins Mauricio Coitiño, Rosario Queirolo, Luis Rivera-Velez Alejandra Triñanes A comparative analysis of policy and Are mothers legalizers? The ambiguities implementation processes adopted in Same laws, different messages: the of layman advocates in cannabis establishing regulated legal drug framing effect on the press coverage of reform in Latin America markets in Colorado, Washington, the regulation of cannabis and alcohol A Uruguay and New Zealand in Uruguay 10:45 am – 12:15 pm
Luca Giommoni, Peter Reuter, Beau Marie Jauffret-Roustide Michael Wiebe Kilmer Drug consumption rooms: issues of The effect of marijuana legalization on The preils of cross national comparisons social acceptability in French public Mexico's drug war of drug prevalence: the effect of survey debate modality
Anke Stallwitz My Lilja April Henning
Community policy at the micro-social Drug discourses in Russian Escalating the war on doping in 2016 level: Utilizing community.mindedness parliamentary debate to reduce violence in the Vancouver and the Stockholm drug scene
12:15 pm – 1:15 pm LUNCH
Wednesday 17th May – Day One
Session Theme Harms, trends & pleasures Policy responses to drug problems Drug Policies and history New Psychoactive Substances Discussant chair TBA TBA TBA TBA Mark Monaghan, Ian Hamilton Simon Lenton, Monica Barratt, Jodie Robin Room Robert Csák, József Rácz Grigg The Risk of benefits: The absence of Legalising after prohibition: alcohol's How environmental factors can pleasure in public health campaigns Deterrent effects of drug detection dogs lessons for other drugs increase the risks of PWIDs - a case and interventions around cannabis at Australian outdoor music festivals: study of Budapest, Hungary Implications for future policy responses
Peter Reuter; Bryce Pardo; Jonathan Rafful Claudia, Orozco R, Rangel G, David McDonald, Alison Ritter Rob Ralphs and Paul Gray Caulkins Davidson P, Gonzalez-Zúñiga P, Werb D, Beletsky L, Strathdee SA. Innovations in drug policy interventions Caught in the act: The impact of the Can sentences for drug offenses over the past decade: an overview and Psychoactive Substances Act on credibly reflect differences in the harms Increased overdose risk associated with assessment vulnerable users of drugs? involuntary drug treatment in a longitudinal study with people who B inject drugs in Tijuana, Mexico 1:15 pm – 2:45 pm
Bryce Pardo Ervant J Maksabedian Mitch Librett Minqi Zhao, Yueming Zhang, Jelle Janssens What relationship does access to The effects of insurance parity on Every doctor a cop; every cop a doctor cannabis have on the consumption of access to medication assisted The effect of criminal sanction on new synthetic cannabinoids? treatments for opioid use disorders psychoactive substance supply reduction: a realist synthesis
Jasmina Burdzovic Andreas; Anne Line Alisa Pedrana, Joseph Doyle, Alex Yun Huang Maurits Beltgens Bretteville-Jensen Thompson, Paul Dietze, Mark Stoove, Jacqui Richmond, Judy Gold, Peter “With a mill-stone about her neck”: Examining the impact of the UK blanket Reday, willing, and able: Higgs, Margaret Hellard China’s role in the 1924-1925 Geneva ban on psychoactive substances on the Deconstructing adolescent cannabis Opium Conferences and its impact UK’s legal high market involvement and associated trends EC!: A partnership to eliminate hepatitis C in Australia
2:45 pm – 3:15 pm AFTERNOON TEA
Wednesday 17th May – Day One
Session Theme Production and Distribution of Cannabis and Harm Reduction Methadone Treatment Prison, Treatment & Drug Use Methamphetamine Discussant chair TBA TBA TBA TBA Steven Davenport Andy Guise, Amen Hamida, Maria Luisa Tim Rhodes, James Ndimbii, Emmy Kageha, Petr Zeman, Michaela Štefunková, Šárka Mittal, Claudia Rafful, Peter Davidson, Daniel Frederick Owiti, Steffanie Strathdee, Andy Blatníková, Kateřina Grohmannová, Tomáš Do marijuana stores increase local traffic Werb Guise Koňák, Ivana Trávníčková accidents? Evidence from Oregon Harm reduction, choice and pleasure in The becoming of methadone treatment in Treatment in an unfavourable setting: structural responses to injecting initiation; Kenya: A qualitative study of Specialized departments for drug users in insights from qualitative research in the implementation Czech prisons Mexico-U.S. border region
Kati Kataja Roya Noori. Zahra Alam-mehrjerdi, Babak Karen Duke Moazen, Nazgol Mostafavinasab, Hooman New practices of harm reduction? Sharing Narenjiha Producing the ‘problem’ of New risk experiences of polydrug use in YouTube Psychoactive Substances (NPS) in British Methadone treatment entry and retention prisons among drug user women in Iran: Implication C for treatment policies, the first study from the 3:15 pm – 5:00 pm most populated Persian Gulf country
Simon Lenton, Vibeke Frank, Monica Barratt, Truong Tuan Dung Thu T.A. Vuong, Nhu T. Nguyen, Nguyen B. Yifen Lu, Yichun Yu, and Chuen-Jim Sheu Gary Potter Nguyen, Huy L. Pham, Huong Q. Nguyen A qualitative and quantitative study to Evaluation of the deferred prosecution Growing practices and the use of chemical critically explore perceptions of harm From free service to co-payment model: practice for drug abusers: An analysis with additives among a sample of small scale reduction policy and practice in Vietnam Effects of the transition on patient big data in Taiwan cannabis growers in three countries adherence and service quality of the Methadone Maintenance Treatment program in Vietnam
Mafalda Pardal Steven Hayle Atul Ambekar, Alok Agrawal, Ashwani Torsten Kolind Mishra, Ravindra Rao “The difference is in the tomato at the end”: A social structural analysis of needle Prison drug treatment: Increasing overlaps understanding the role and practices of exchange policy in Canada and the UK Do drug policies impede the availability of between social service and punishment cannabis growers operating within Belgian treatment of opioid dependence in India cannabis social clubs (and more so for non-injecting opioid users)? Analysis of epidemiological data from Punjab, India
Jason Ferris Modupe Onigbogi, Omobola Ojo Zahra Alammehrjerdi, Afsaneh Moradi Kirsty Kruithof, Matthew Davies, Emma Disley, Lucy Strang and Kei Ito The disruption of Australian domestic Willingness to join drug free clubs by elderly Drug treatment and harm reduction methamphetamine production: Analysis of persons in Lagos, Nigeria programmes for women in Iran: the first Mapping the use of alternatives to coercive pseudoephedrine-based medication sales women-sensitive policy in Western Asia sanctions as a response to drug law offen- data ces and drug-related crimes across the EU
5:30 pm – 7:30 pm WELCOME RECEPTION ARoS Aarhus Art Museum Thursday 18th May – Day Two
8:30 am – 9:15 am Registration 9:15 am – 10:00 am Keynote Presentation: Alejandro Madrazo Lajous: The Constitutional Costs of the War on Drugs Chair: TBA 10:00 am – 10:30 am MORNING TEA Session Theme Darknet and cryptomarkets Performance and Image Enhancing Drug policy differentiation Researchers and drug use Drugs Discussant chair TBA Katinka van de Ven Vibeke A. Frank Monica Barratt Sara Rolando Panel 8: HED policy: Performance and Panel 1: Drug policy differentiation: Workshop: Image Enhancing Drugs accommodating diversity and Are we ready to come out? Discretion, The NPS on the darknet – a pilot study marginality disclosure, identity and the drug Panelists: researcher’s drug use. Katinka van de Ven Panelists: Ask Vest Christensen Elizabeth Ettorre Monica Barratt with Judith Aldridge, Bertrand Fincoeur Emma Wincup Gary Potter and Anna Ross Larissa L. Maier, Monica Barratt, Jason Anders Vinther Daniel Bear Ferris, Adam Winstock Aileen O’Gorman
Do zero tolerance drug policies promote NPS and darknet market use?
D 10:30 am – 12:00 pm Kim Masson
‘Nice people doing shady things’: The morality of exchange in darknet cryptomarkets
Kirsty Kruit, Judith Aldridge, David Decary-Hetu, Megan Sim, Elma Dujso, Stijn Hoorens.
The role of the ‘dark web’ in the trade of illicit drugs
12:00 pm – 1:00 pm LUNCH 1:00 pm – 1:30 pm POSTER SESSION IN ROOM xx
Thursday 18th May – Day Two
Session Theme Cryptomarkets Cognitive Enhancement Drugs Selling drugs Drug monitoring and policy indexes Discussant chair Monica Barratt Jeanett Bjønness TBA TBA Panel 7: Cryptomarkets – recent Panel 7: HED policy: Cognitive Cecep Mustafa Peter Meylakhs, Eric Sevigny empirical developments and enhancement drugs theoretical perspectives ”She/he strives for justice and Development of a global policy index Panelists: beneficiary, although it will abandon measuring national commitments to Panelists: Jeanett Bjønness legal certainty somewhat”: Judicial HIV prevention and treatment among David Decaru-Hetu Lea Trier Krøll perspective on the sentencing of minor people who inject drugs Jakob Demant Scott Vrecko drug offender in Indonesia Monica Barratt Aleksi Hupli Meropi Tzanetakis Gabija Didziokaité Judith Aldridge Marte Ydema Rasmus Munksgaard Bernd Werse, Dirk Egger Eric Sevigny
“I don’t do this because I want to get When DAWN went dark: can health rich” – a comparative analysis of profit costs and utilization project (HCUP) E oriented drug-dealers in Germany serve as a cost-effective and reliable 1:30 pm – 3:00 pm alternative to the defunct drug abuse warning network (DAWN)?
Judith Aldridge, Lisa Williams, Tom Angelica Meinhofer Decorte Prescription drug monitoring programs: Can profitable drug selling activity be the role of asymmetric information on understood as normalized? Drug drug availability and abuse cryptomarket sellers as drug reform activists
Vivienne Moxham-Hall, Caitlin Hughes, Alison Ritter
The development and application of an Australian cannbis law index
3:00 pm – 3:30 pm AFTERNOON TEA 3:30 pm – 4:15 pm Keynote Presentation: Rosalie Pacula: : Into the Weeds: Why Details Matter for Properly Evaluating the Effects of Changing Marijuana Policies Chair: TBA
Thursday 18th May – Day Two
Session Theme Different policy, different Treatment: complexity and comparison Mapping drug markets in different Costs of drugs consequences ways Discussant chair TBA TBA TBA TBA Stephen Rolles, Fiona Measham, Ole Bagga Bjerge, Jeppe Oute, Louise Julian Broseus, Natacha Gentile, Simon Laura Atuesta Rogeberg Christensen Baechler, Marie Morelato, Pierre Esseiva Since the benefits are uncertain, can Using multi criteria decision analysis Complex cases – complex policies Studying illicit drug markets through the we evaluate prohibition examining its (MCDA) to assess different policy analysis of its central component: how costs? responses to non-medical heroin use to provide intelligence by profiling law enforcement seizures
Daniel Mauricio Rico Jessica Storbjörk, Jeanette Mugavin Daan van der Gouwe, Tibor Brunt, Anne Line Bretteville-Jensen, Claudia Magriet can Laar, Peggey van der Pol Costa Storti, C. Mikulic, F. Trigueiros, F. Alternative development and drugs Events in problematic substance users’ Papamalis, P. Piscociu, Kattau supply reduction: who gets the lives and paths to treatment: Purity, adulteration and price of drugs benefits? comparing the prohibitionist Sweden to bought online versus offline in the Public expenditure on supply reduction the harm-minimizing Australia Netherlands policies
Luca Di Censi, Francesco Fabi, Carla AM Tucci, AW Stevens Jonathan Caulkins, Yilun Bao, Imane Claudia Costa Storti, Charlotte Davies Rossi Fahli, Yutian Guo, Krista Kinnard, Mary Barriers and difficulties to access drug Najewicz, lauren Renaud. Estimating public expenditure on drug F Drug policy evaluation: criminal career treatment in Brazil and England treatment – conclusions from an insights 4:20 pm – 5:30 pm of drug users and new indicators of Big data on a big new market: Insights health and law enforcement about suppliers and customers in Washington State’s legal cannabis market
Frank Renato Casas Sulca Lynda Berends Kim Møller
Scenarios and social actors as key Ploicy reform regarding the ‘problem’ of Price formation in illicit drug markets – determinants of drug policy in Peru: two centralized assessment in Victoria’s an economic sociological perspective comparative cases on coca leaf control drug treatment sector
Claudia Rafful, Devesh Vashishtha, SeyedehNazgol Mostafavinasab, Roya Patricia Gonzales-Zuniga, Peter Noori, Omid Massah, Babak Moazen, Ali Davidson, Dan Werb, Andy Guise Farhoudian, Reza Daneshmand, Sepideh Aryanfard Drug policy implications of pathways to initiation of injection drug use Women-only therapeutic community facilitated by people who inject drugs program and treatment needs in Iran: in Tijuana, Mexico the first study from the most populated Persian Gulf country 5:30 pm – 6:30 pm ISSDP Annual General Meeting 7:00 pm – 9:30 pm CONFERENCE DINNER at CANBlau Friday 19th May – Day Three
8:30 am – 9:00 am Registration 9:00 am – 9:45 am Keynote Presentation: Eugene Raikhel Chair: TBA Session Theme Alternative regulatory models for Developing drug supply indicators Methodology and drug policy research. Research funding sources and conflicts cannabis of interest Discussant chair Simon Lenton Caitlin Hughes TBA Alison Ritter Panel 5: Alternative regulatory models Panel 3: Developing drug supply Katrine Syppli Kohl Panel 4: Research funding sources and for cannabis in four countries indicators to improve policy monitoring, conflicts of interest: understanding analysis and practice Risk, knowledge and willful ignorance: diverse policy positions Panelists: Narratives of being knowledgeable in Jonathan Caulkins Panelists: interviews with high-risk drug users Panelists: Beau Kilmer Nicola Singleton Helen Keane Tom Decorte Matthew J.A. O’Reilly Gerry Stimson Chris Wilkins Teodora Groshkova Robin Room Eric Costen Marieke Liem Alissa Greer, Bernadette Pauly, Alex Alex Stevens Scott, Ruth Elwood Martin, Charlene Kerstin Stenius Burmeister, Jane Buxton
Payer and Payee: principles and strategies for paying people who use substances for the participation at G policy making tables 9:50 am – 11:00 am
Peter Davidson, Rebecca Fielding- Miller, Ricky Bluthenthal.
Ethical collaborations between researchers and community organisations serving people who use drugs
Rebecac Ascew
From apathy to activism: understanding drug takers perspectives on the law and policy
11:00 am – 11:20 am MORNING TEA
Friday 19th May – Day Three
Session Theme The Uruguyan Cannabis Model Drug trafficing Drug user perspectives Policing drugs: practices and (un-) intended outcome Discussant chair Pablo G. Palermo TBA TBA TBA Panel 2: The Uruguyan cannabis Sheryl McCurdy Samhita Bhushan, Atul Ambekar, M. Morales, ML. Mittal, T. Rocha, J. model: update and open issues Abhay Jain Arredondo, J. Cepeda, SA. Strathdee, L. Pawns in Makran: Tanzanians, debt Beletsky Panelists: bondage, and drug trafficking Attitudes and perceptions of retailers Pablo G. Palermo strategies and consumers of legal cannabis Translating drug policy reform: A Marcos Baudeaun (bhang) in India qualitative study of policy officer Jose Miguel Cruz knowledge, perceptions, and beliefs Ricardo Fraiman following a training on Mexico’s Veronika Claassen Narcomeudeo law Hai Thanh Luong Osasuyi Dirisu, Darren Shickle, Helen Alison Ritter, Caitlin Hughes, Kari Elsey. Lancaster, Rob Hope The nature of cross-border drug trafficing in the Mainland Southeast Perspectives on young cannabis users Drug detection dogs seen through the Asia Region: An example across within the Nigerian policy context: The eyes of the Advocacy Coalition Vietnam’s borderland and Lao PDR paradox of criminalization as a Framework compared to Multiple deterrence strategy Streams: the science policy nexus H 11:20 am – 12:50 pm Allan Gillies Paul Gray, Rob Ralphs, Anna Norton. Caitlin Hughes, Vivienne Moxham-Hall, Alison Ritter, Rob McCoun, Don State-Narco Networks and the ‘War on ‘Green heroin’: Synthetic cannabinoid Weatherburn Drugs’ in Post-Transition Bolivia (1989- use amongst the homeless in the north 1993) of England Going out in Sydney: a three month prospective study of the impacts of street-level policing on illicit drug use at outdoor music festivals and licensed entertainment precincts
Angelica Duran-Martinez Charlotte de Kock, Bert Hauspie, Ilse Thomas Friis Søgaard, Esben Houborg Derluyn, Tom Decorte, Wouter Vander The impact of marijuana legalization in plasschen, Julie Schamp. Voices of the banished: young people’s the U.S. on Mexican trafficking groups experiences of and resistance to A qualitative exploration of perceived nightlife zonal banning orders discrimination, ethnic identity and ethnic network and their relation to substance use in people with a Turkish and Eastern-European migration backgroung in Ghent, Belgium
12:50 pm – 1:45 pm LUNCH
Friday 19th May – Day Three
Session Theme Medical cannabis Harm Reduction New theories in drug policy? Human Rights and UN language Discussant chair TBA Alex Stevens TBA TBA Marcus Asplund Panel 6: New developments in harm Vanessa Gstrein Ediomo-Ubong Nelson reduction: panel of the ISSDP/ESC joint The effects of full legalization on the working group on European drug policy Ideation, social construction and drug Criminalization of drug use and human medical cannabis market in Colorado: policy: a scoping review rights: Narratives of police crackdowns Implications for prescription policy Panelists: in Uyo, Nigeria Camille Stengel William Floodgate Fiona Measham Edgar Guerra Anna Ross Melissa Bone
Prohibition or legalization. The dispute Developing a Critical Drug Theory: the Politicising human rights as a tool for over medical use or recreational role of narrative, knowledge and the UK’s Cannabis Social Club consumption of cannabis in Mexico participation. Movement
I 1:45 pm – 3:15 pm Sharon Sznitman Eric A. Ratliff Jaazeal Jakosalem
Do recreational cannabis users, “A totally different atmosphere”: Co- Examining the abuses of extra-judicial unlicensed and licensed medical producing drug contexts through approach of the drug problem in the cannabis users form a distinct group? narrative emplacement Philippines, and seeking policy-level solutions based on human rights and rule of law
Axel Klein, Gary Potter Daniel Bergsvik, Ole Rogeberg Jamie Bridge, Christopher Hallam Dave Bewley Taylor, Marie Nougier, Martin The Righteous drug fiend revisited – the How can empirical indicators of drug Jelsma three fold grievance of medical use and policy efforts be useful cannabis growers in the UK decision-support tools for drug policy? Edging forward: How the UN's language on drugs has advanced since 1990
3:20 pm – 3:45 pm Conference Closing Ceremony and invitation to ISSDP 2018: ……